Kevin Baranger, Ph.D

Affiliations: 
Université de la Méditerranée, Marseille, Provence-Alpes-Côte d'Azur, France 
Google:
"Kevin Baranger"
Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zipfel P, Rochais C, Baranger K, et al. (2020) Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges. Journal of Medicinal Chemistry
Rochais C, Lecoutey C, Hamidouche K, et al. (2019) Donecopride, a Swiss army knife with potential interest against Alzheimer's disease. British Journal of Pharmacology
García-González L, Pilat D, Baranger K, et al. (2019) Emerging Alternative Proteinases in APP Metabolism and Alzheimer's Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP. Frontiers in Aging Neuroscience. 11: 244
Baranger K, van Gijsel-Bonnello M, Stephan D, et al. (2019) Long-Term Pantethine Treatment Counteracts Pathologic Gene Dysregulation and Decreases Alzheimer's Disease Pathogenesis in a Transgenic Mouse Model. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics
Rivera S, García-González L, Khrestchatisky M, et al. (2019) Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders. Cellular and Molecular Life Sciences : Cmls
Paumier JM, Py NA, García-González L, et al. (2018) Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201801076R
van Gijsel-Bonnello M, Baranger K, Benech P, et al. (2018) Correction: Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine. Plos One. 13: e0194586
Morello M, Landel V, Lacassagne E, et al. (2018) Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer's Disease. Molecular Neurobiology
Baranger K, Giannoni P, Girard SD, et al. (2017) Chronic treatments with a 5-HT4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease. Neuropharmacology
Girard SD, Virard I, Lacassagne E, et al. (2017) From Blood to Lesioned Brain: An In Vitro Study on Migration Mechanisms of Human Nasal Olfactory Stem Cells. Stem Cells International. 2017: 1478606
See more...